Human basic fibroblast growth factor analog
US6294359A · kind A · utility
50Cited by
5References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 16, 1998 |
| Grant date | Sep 25, 2001 |
| Priority date | — |
| Expiry date | Jun 16, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2830/55
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The DNA sequences encoding analogs of human acidic and basic fibroblast growth factors (FGF) can be recombinantly expressed to obtain practical amounts of proteins useful in effecting both pathologies related to persistent angiogenesis and wound healing and related tissue repair.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.